HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol-Myers aims for savings of up to $1.5 bil. in 1998 via improved productivity.

This article was originally published in The Rose Sheet

Executive Summary

BRISTOL-MYERS SQUIBB PRODUCTIVITY INITIATIVES WILL LEAD TO $1.1-$1.5 BIL. SAVINGS through 1998, the company told analysts Dec. 11. BMS said company-wide productivity initiatives are projected to result in gains of $1.1 bil. to $1.5 bil. pretax through 1998 with "associated future restructuring charges," including a 1995 year-end pretax restructuring charge of $250 mil. to $300 mil. due to current accounting rules.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel